Clinical Trial Update: Phase II Trial of LBH589 in Refractory Colorectal Cancer [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase II trial of LBH589 (panobinostat) in patients with refractory colorectal cancer and provides an update on the tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• LBH589 (panobinostat)

Snippet

Sponsor: Swedish Medical Center | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED